OMX30 1 613 -0,3%  OMXH25 3 941 -0,3%  OMXC20 1 001 -0,4%  Dow 23 526 -0,3%  Nas 6 386 0,1%  EUR 9,8303 0,0%  USD 8,2963 0,0%  Olja 63,4 -0,1%  Guld 1 292 0,2% 

Baxter International Aktie

64,03USD -0,23USD -0,36%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Baxter International Chart - 1 År - BTT

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,60 0,71 0,83 0,80
Direktavkastning (i %) 1,15 1,32 1,58 1,85 1,77
PE-tal 22,22 18,58 16,66 14,61 13,18
Resultat/aktie 1,96 2,43 2,71 3,09 3,42

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 64,03
-0,4%
Boston Scientific 28,47
-1,1%
Cardinal Health 56,97
2,3%
Covidien 0,00
0,0%
Fresenius Medical Care 82,50
-0,2%
Fresenius 61,44
-1,1%
Hospira 0,00
0,0%
Medtronic 82,33
-0,4%
STRATEC Biomedical 68,00
-2,9%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.till bolagsprofilen

Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug reconstitution systems; and pharmacy automation, software and services. The company products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid 63,94 USD Ask 64,04 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 64,03 USD -0,23 -0,36 %
Kurstid 21:59:59
Datum 22.11.2017
Öppning 64,30
Gårdagen 64,26
Dagshögsta 64,61
Dagslägsta 63,84
52 v. högsta 65,70
52 v. lägsta 43,14
52 v. perf.
Volym (Antal) 90 865
Börsvärde (SEK) 291,13 Mrd
Börsen
Kurs för 64,03 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 531,21 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 500, BX Swiss - USA, S&P 100, NYSE US 100

Baxter International Nyckeltal

Börsvärde i SEK 291,13 Mrd
Free float % 99,83
Antal aktier mio. 541,96
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 24,76
PBV 2,56

Baxter International Historiska kurser

2017-11-22 64,03 90 865
2017-11-21 64,26 201 979
2017-11-20 63,87 165 207
2017-11-17 63,88 254 543
2017-11-16 65,00 98 453